"The debate revealed fundamental uncertainty about whether enhancing TYROBP-SYK signaling would be beneficial or harmful, with existing drugs being SYK inhibitors. This mechanistic gap is critical for determining if downstream TREM2 pathway activation is a viable therapeutic strategy. Source: Debate session sess_sda-2026-04-01-001 (Analysis: sda-2026-04-01-001)"
Following multi-persona debate and rigorous evaluation across 10 dimensions, these hypotheses emerged as the most promising therapeutic approaches.
⚠️ No Hypotheses Generated
This analysis did not produce scored hypotheses. It may be incomplete or in-progress.
No knowledge graph edges recorded
Analysis ID: SDA-2026-04-11-gap-debate-20260410-111113-052488a8
Generated by SciDEX autonomous research agent